AROC.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Diagnostics & Research

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E
2026	$80M	+20.9%	$0.00	$0.00–$0.00	—
2027	$105M	+30.0%	$0.00	$0.00–$0.00	—
2028	$138M	+32.1%	$0.00	$0.00–$0.00	—

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
AROC.STAroCell AB (publ)	$0.57	+0.00%	$132M	—
AEGIR.STAegirBio AB (publ)	$0.43	+3.88%	$15M	—
COMBI.STCombiGene AB (publ)	$2.47	-3.89%	$49M	—
DIGN.STDignitana AB (publ)	$2.14	-6.14%	$172M	—
EMPLI.STEmplicure AB (publ)	$0.47	+0.86%	$46M	—
FRISQ.STFRISQ Holding AB (publ)	$0.70	+6.38%	$47M	—
IRRAS.STIRRAS AB (publ)	$0.16	-1.11%	$182M	—

Source: Financial Modeling Prep · peers by sector/industry

AroCell AB (publ)

AroCell AB (publ) is an in vitro diagnostics enterprise primarily focused on the surveillance of various cancerous conditions, such as hematological malignancies, breast cancer, and other solid tumors. The company develops, produces, and markets its flagship product, AroCell TK 210 ELISA, an immunoassay kit designed for measuring Thymidine Kinase 1 levels in human blood. Additionally, AroCell provides TUBEX TF, a rapid bacteriological test for the detection of typhoid fever. Founded in 2000, the firm was originally known as Xi Bao Research AB, adopting its current name, AroCell AB (publ), in 2006. It maintains its headquarters in Uppsala, Sweden.

www.arocell.com

Employees: 22
IPO / List date: May 25, 2011
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds AROC.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in AROC.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded AROC.ST yet.